Cancer name Colon Carcinoma
Cancer Type COCA
Immunotherapy type Adoptive Cell Therapy
Treatment Antartina
Drugstatus NA
Drugbank ID NA
Checkpoints NA
Signature Type Protein
Signature CD11c
Official Symbol ITGAX
Mode of action PROT_D_UP
Description for ‘mode of action’:the ‘mode of action’ for signature is composed of three parts: A_B_C. A describes the level at which the corresponding signature changes, it may contain the following values: TRAN(translation), PROT(protein), CE(cell), METH(methylation), AC(acetylation), PHOS(phosphorylation), MU(mutation), SNP(single nucleotide polymorphism), GLYC(glycosylation) and PATH(pathway). B describes the corresponding signature in which cancer immunotherapy condition group has changed, it may contain the following values: R (immunotherapy response group), NR(immunotherapy non-response group), D (Immunotherapy group), ND (No immunotherapy group). C describes the change detail (specific direction) of the corresponding signature, it may contain the following values: UP (High gene/protein expression or increased cellular abundance or enhanced epigenetic modification), DN (Low gene/protein expression or reduced cellular abundance or attenuated epigenetic modifications), LOSS (deletion mutation), GAIN (gain mutation),Other. For example, the search/browse detail result for CD274 was “PROT_R_UP”, it can be interpreted that the protein level of CD274 was upregulated in immunotherapy response individuals.
Experimental Mouse model
Description We then analyzed the prevalence of T lymphocytes in tumor samples by flow cytometry and detected an increased proportion of tumor-infiltrating CD4+ and CD8+ Tcells in Antartina-treated mice in comparison with controls
PMID 29483221
Title A Tricin Derivative from Deschampsia antarctica Desv.In hibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response